Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin-Prophylactic Labour Use Study
PACTR202004580322097Phase 4Recruiting
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Maternal infection, neonatal infection and sepsis comparing Azithromycin with Placebo (2 arms). Primary endpoints: Maternal death or sepsis, Intrapartum/neonatal death or sepsis by 7 days and 1 more. Started Apr 2020; status: recruiting.
02
Drugs
azithromycin
03
Conditions
Maternal infectionneonatal infectionsepsis
Beyond the preview
Go deeper on PACTR202004580322097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202004580322097.